share_log

Stifel Maintains Buy on Sabra Health Care REIT, Raises Price Target to $16

Stifel Maintains Buy on Sabra Health Care REIT, Raises Price Target to $16

Stifel維持對Sabra Health Care REIT的買入,將目標股價提高至16美元
Benzinga ·  2023/11/07 10:10

Stifel analyst Stephen Manaker maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Buy and raises the price target from $14 to $16.

Stifel分析師斯蒂芬·馬納克維持Sabra Health Care REIT(納斯達克股票代碼:SBRA)的買入,並將目標股價從14美元上調至16美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論